New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Can-Fite Biopharma Ltd (CANF) vs Heatwurx Inc. (PCSA)
- Can-Fite Biopharma Ltd CANF 1.47 −2.65%
- Heatwurx Inc. PCSA 1.67 −1.76%
Can-Fite Biopharma Ltd and Heatwurx Inc. are both Biotechnology companies. Can-Fite Biopharma Ltd and Heatwurx Inc. are of similar size ($4.8M and $4.6M). Can-Fite Biopharma Ltd grew revenue faster over the last twelve months: −3.36% against −34.5%. Heatwurx Inc. has the higher net margin (0.00% vs −1,148.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Heatwurx Inc. leads on 7 and Can-Fite Biopharma Ltd on 5.
Valuation
Profitability
| Metric | CANF | PCSA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (1,148.62%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 220.06% | (51.58%) |
| Return on assets | 0.00% | (203.76%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack